LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Novel Device Yields Close-Up Look at Metastasis

By LabMedica International staff writers
Posted on 16 Nov 2014
Print article
Image: The Nikon Eclipse TE2000-U Inverted Fluorescence Microscope (Photo courtesy of Carmet Scientific).
Image: The Nikon Eclipse TE2000-U Inverted Fluorescence Microscope (Photo courtesy of Carmet Scientific).
A laboratory device has been invented that gives an unprecedented microscopic look at metastasis, the complex way that tumor cells spread through the body, causing more than 90% of cancer-related deaths.

One difficulty in studying metastasis stems from the complexity of the interface between the tumor microenvironment and the vascular system, but the newly developed investigational platform positions tumor cells next to an artificial vessel embedded in an extracellular matrix (ECM).

Scientists at Johns Hopkins University (Baltimore, MD, USA) used live-cell fluorescence microscopy to analyze the complex interplay between metastatic cancer cells and a functional artificial microvessel that was lined with endothelial cells. The ECM/vessel platform is composed of a cylindrical collagen channel located within a polydimethylsiloxane (PDMS) housing that is perfused by a gravity flow system.

Time-lapse, phase-contrast, and fluorescence images were captured using automated image acquisition software with a TE-2000 U microscope (Nikon; Tokyo, Japan). A 10× objective was used for all epifluorescence and phase-contrast imaging. Permeability was measured through quantitative fluorescence detection of molecular transport from inside the vessel to the surrounding ECM. A nutrient-rich solution flows through the artificial vessel, mimicking the properties of blood. The breast cancer cells, inserted individually and in clusters in the tissue near the vessel, are labeled with fluorescent tags, enabling their behavior to be seen, tracked and recorded via a microscopic viewing system.

The investigators were able to record video of the movement of individual cancer cells as they crawled through a three-dimensional collagen matrix. This material resembles the human tissue that surrounds tumors when cancer cells break away and try to relocate elsewhere in the body. This process is called invasion. They were able video single cancer cells prying and pushing their way through the wall of an artificial vessel lined with human endothelial cells, the same kind that line human blood vessels. By entering the bloodstream through this process, called intravasion, cancer cells are able to hitch a ride to other parts of the body and begin to form deadly new tumors.

Peter C. Searson, a professor and senior author of the study said, “We were able to build a functional artificial blood vessel and a microenvironment that lets us capture the details of the metastatic process. In the past it's been virtually impossible to see the steps involved in this process with this level of clarity. We've taken a significant leap forward.” The study was published on September 1, 2014, in the journal Cancer Research.

Related Links:

Johns Hopkins University 
Nikon 



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more